Header Logo

Connection

MICHAEL MANCINI to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications MICHAEL MANCINI has written about Histone Deacetylase Inhibitors.
MICHAEL MANCINI
Connection Strength
0.024
Histone Deacetylase Inhibitors
  1. CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy. Horm Cancer. 2016 06; 7(3):196-210.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.